Suggested Readings

  • 1
    Hayes SN, Taler SJ. Hypertension in women: current understanding of gender differences. Mayo Clin Proc. 1998;73(2):157165.
  • 2
    Lewis CE. Characteristics and treatment of hypertension in women: a review of the literature. Am J Med Sci. 1996;311(4):193199.
  • 3
    Safar ME. Smulyan H. Hypertension in women. Am J Hypertens. 2004;17(1):8287.
  • 4
    Oparil S. Women and hypertension: what did we learn from the Women's Health Initiative? Cardiol Rev. 2006;14(6):267275.
  • 5
    Wassertheil-Smoller S, Anderson G, Psaty BM, et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension. 2000;36:780789.
  • 6
    Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294:466472.
  • 7
    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:29812997.
  • 8
    Julius S, Kjeldsen S, Weber M, et al; VALUE Trial Group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet. 2004;363:20222031.
  • 9
    Dahlõf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomized controlled trial. Lancet. 2005;366:895906.
  • 10
    Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:12061252.
  • 11
    Lipsitz LA, Iloputaife I, Gagnon M, et al. Enhanced vaso reactivity and its response to antihypertensive therapy in hypertensive elderly women. Hypertension. 2006;47(3):377383.
  • 12
    Higgins JR, de Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet. 2001;357:131135.
  • 13
    Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327:955964.
  • 14
    National HBPEP Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(suppl):S1S22.
  • 15
    Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525541.
  • 16
    Igho-Pemu P, Lapu-Bula R, Li R, et al. P-556: Differential effect of body weight and systolic blood pressure on nitric oxide-dependent vasodilation in normotensive versus hypertensive African American women. Am J Hypertens. 2002;15:235A.
  • 17
    Igho-Pemu P, Quarshie A, Oduwole AO, et al. Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education. Ethn Dis. 2005;15(4 suppl 5):S5-120S5-123.